Literature DB >> 2150505

Meta-analysis of Italian clinical trials of nabumetone.

G Vaiani1, E Grossi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2150505     DOI： 10.2165/00003495-199000405-00011

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  4 in total

1.  Comparison of the safety and efficacy of nabumetone and aspirin in the treatment of osteoarthritis in adults.

Authors:  D J Appelrouth; S Baim; R W Chang; M H Cohen; D W Englund; B F Germain; S S Hartman; A Jaffer; B J Mullen; F E Smith
Journal:  Am J Med       Date:  1987-10-30       Impact factor: 4.965

2.  Single-blind comparative study of nabumetone (Relafen) versus naproxen in the treatment of rheumatoid arthritis.

Authors:  B L Hazleman; P P Thomas
Journal:  Am J Med       Date:  1987-10-30       Impact factor: 4.965

3.  Nabumetone (BRL 14777, 4-[6-methoxy-2-naphthyl]-butan-2-one): a new anti-inflammatory agent.

Authors:  E A Boyle; P C Freeman; F R Mangan; M J Thomson
Journal:  J Pharm Pharmacol       Date:  1982-09       Impact factor: 3.765

4.  Double-blind crossover study of nabumetone versus naproxen in the treatment of osteoarthritis.

Authors:  L A Verbruggen; E Cytryn; H Pintens
Journal:  J Int Med Res       Date:  1982       Impact factor: 1.671
  4 in total
  1 in total

1.  Nabumetone. A reappraisal of its pharmacology and therapeutic use in rheumatic diseases.

Authors:  H A Friedel; H D Langtry; M M Buckley
Journal:  Drugs       Date:  1993-01       Impact factor: 9.546
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.